fibrinogen has been researched along with Ventilator-Associated Pneumonia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alberio, L; Artru, F; Casini, A; Chtioui, H; Fraga, M; Moradpour, D; Neerman-Arbez, M; Romailler, E; Schneider, A; Sempoux, C; Tschopp, J | 1 |
Altmayer, V; Cao, A; Demeret, S; Gallo, A; Le Guennec, L; Marois, C; Rohaut, B; Saheb, S; Weiss, N | 1 |
2 other study(ies) available for fibrinogen and Ventilator-Associated Pneumonia
Article | Year |
---|---|
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Diagnosis, Differential; Fibrinogen; Glycogen Storage Disease Type IV; Hepatitis; Hepatitis B, Chronic; Humans; Inclusion Bodies; Lafora Disease; Liver; Liver Function Tests; Male; Middle Aged; Pandemics; Patient Care Management; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Embolism; Respiration, Artificial; SARS-CoV-2; Treatment Outcome | 2020 |
Therapeutic plasma exchange in a critically ill Covid-19 patient.
Topics: Aged; Albumins; C-Reactive Protein; Combined Modality Therapy; COVID-19; Critical Illness; Cytokine Release Syndrome; Fibrinogen; Humans; Interleukin-6; Male; Oxygen; Oxygen Inhalation Therapy; Plasma Exchange; Pneumonia, Ventilator-Associated; Respiration, Artificial; Respiratory Distress Syndrome; Salvage Therapy; SARS-CoV-2; Solutions | 2021 |